Published on
January 5, 2026
- 10:36 GMT
Huadong and MC2 Therapeutics Announce Strategic Collaboration for Biomee® Creams in Greater China
MC2 Therapeutics grants Huadong exclusive Greater China rights to PAD Technology® powered Biomee® creams designed to address itch and dry skin. COPENHAGEN, DENMARK, January 5, 2026 /EINPresswire.com/ -- Hangzhou Zhongmei Huadong Pharmaceutical Co (“ …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
